72 related articles for article (PubMed ID: 21172896)
1. Looking at the seemingly contradictory role of vinblastine in anaplastic large-cell lymphoma from a metronomic perspective.
André N; Pasquier E; Gentet JC; Kamen BA
J Clin Oncol; 2011 Feb; 29(4):e90-1; author reply e92-3. PubMed ID: 21172896
[No Abstract] [Full Text] [Related]
2. Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.
Le Deley MC; Rosolen A; Williams DM; Horibe K; Wrobel G; Attarbaschi A; Zsiros J; Uyttebroeck A; Marky IM; Lamant L; Woessmann W; Pillon M; Hobson R; Mauguen A; Reiter A; Brugières L
J Clin Oncol; 2010 Sep; 28(25):3987-93. PubMed ID: 20679620
[TBL] [Abstract][Full Text] [Related]
3. Long-term disease control of refractory anaplastic large cell lymphoma with vinblastine.
Garner R; Li Y; Gray B; Zori R; Braylan R; Wall J; Hunger SP
J Pediatr Hematol Oncol; 2009 Feb; 31(2):145-7. PubMed ID: 19194204
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic large cell lymphoma presenting as hemophagocytic syndrome in an adolescent.
Sovinz P; Lackner H; Schwinger W; Benesch M; Urban C; Beham-Schmid C
Pediatr Blood Cancer; 2007 Dec; 49(7):1057. PubMed ID: 17941063
[No Abstract] [Full Text] [Related]
5. Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial.
Wrobel G; Mauguen A; Rosolen A; Reiter A; Williams D; Horibe K; Brugières L; Le Deley MC;
Pediatr Blood Cancer; 2011 Jul; 56(7):1071-7. PubMed ID: 21280197
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of a child with refractory anaplastic large cell lymphoma following therapy with an antisense oligonucleotide, topotecan, and vinblastine.
Wrobel G; Chaber R; Rygier J; Bonar J; Muszynska-Roslan K; Chybicka A
Hematol Oncol; 2015 Mar; 33(1):52-5. PubMed ID: 21809366
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous anaplastic large cell lymphoma.
Daar G; Küpeli S; Yalçin B; Kesik V; Orhan D; Büyükpamukçu M
Pediatr Hematol Oncol; 2010 Oct; 27(7):558-63. PubMed ID: 20624005
[TBL] [Abstract][Full Text] [Related]
8. Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Mandal S; Varma K; Jain S
Cytopathology; 2008 Apr; 19(2):127-9. PubMed ID: 18070116
[No Abstract] [Full Text] [Related]
9. Successful treatment with daclizumab of refractory anaplastic lymphoma.
Costa V; Oliva T; Norton L
Pediatr Blood Cancer; 2009 Dec; 53(6):1130-1. PubMed ID: 19598219
[TBL] [Abstract][Full Text] [Related]
10. [Ki-1+ large-cell anaplastic lymphoma with a leukemic appearance. Study of a case].
Rabasa P; Domingo JM; Quílez D; Monzón F
Sangre (Barc); 1998 Jun; 43(3):240-3. PubMed ID: 9741234
[TBL] [Abstract][Full Text] [Related]
11. A case of anaplastic large cell lymphoma-induced hemophagocytic lymphohistiocytosis in an adolescent female.
Krenova Z; Sterba J; Blatny J; Kren L; Slany J
Pediatr Blood Cancer; 2007 Dec; 49(7):1056. PubMed ID: 17405157
[No Abstract] [Full Text] [Related]
12. [Anaplastic large cell lymphoma associated with tuberculoid granulomatous reaction: report of a case].
Li SM
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):124-5. PubMed ID: 16630494
[No Abstract] [Full Text] [Related]
13. [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].
Qiu H; Wang GM
Ai Zheng; 2007 Dec; 26(12):1392-6. PubMed ID: 18076810
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid.
Chou WC; Su IJ; Tien HF; Liang DC; Wang CH; Chang YC; Cheng AL
Cancer; 1996 Oct; 78(8):1805-12. PubMed ID: 8859196
[TBL] [Abstract][Full Text] [Related]
15. Systemic anaplastic large cell lymphoma presenting with conjunctival involvement.
Clarke B; Legodi E; Chrystal V; Govender D
Arch Ophthalmol; 2003 Apr; 121(4):568-70. PubMed ID: 12695256
[No Abstract] [Full Text] [Related]
16. Long-term remission of children with relapsed and secondary anaplastic large cell non-Hodgkin lymphoma (ALCL) following treatment with pulsed dexamethasone and low dose etoposide.
Stockklausner C; Behnisch W; Mechtersheimer G; Möller P; Kulozik AE
Pediatr Blood Cancer; 2008 Jan; 50(1):126-9. PubMed ID: 16609950
[TBL] [Abstract][Full Text] [Related]
17. [Retroperitonal fibrosis and lymphoma in a 15-year-old boy].
Milcent K; Franchi-Abella S; Larrar S; Guitton C; Valteau-Couanet D; Koné-Paut I; Bader-Meunier B
Arch Pediatr; 2008 Dec; 15(12):1756-9. PubMed ID: 18976891
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-rich anaplastic large cell lymphoma expressing interleukin-8.
Miyagawa T; Sugaya M; Okada A; Asano Y; Kadono T; Sato S
Acta Derm Venereol; 2014 Nov; 94(6):741-2. PubMed ID: 24676630
[No Abstract] [Full Text] [Related]
19. Asynchronous burst-suppression in a child with callosal Ki-1 anaplastic large cell lymphoma.
Hukin J; Davey A; Wong P; Hendson G; Aquino-Parsons C; Wu J; Sargent M
Neurology; 2005 Sep; 65(6):947-9. PubMed ID: 16186544
[TBL] [Abstract][Full Text] [Related]
20. Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology.
Brugières L; Pacquement H; Le Deley MC; Leverger G; Lutz P; Paillard C; Baruchel A; Frappaz D; Nelken B; Lamant L; Patte C
J Clin Oncol; 2009 Oct; 27(30):5056-61. PubMed ID: 19738127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
